Led the IPO readiness of an early-stage gene therapy company

Led the IPO readiness of an early-stage gene therapy company

Gaeton and his team led the IPO readiness for the finance team of an early-stage gene therapy company.

Our client needed a first-time audit and filing completed within forty-five days. We addressed all complex accounting transactions, drafted all financial information within the registration statement, and completed the project within only forty days, resulting in minimal SEC comments when reviewed by the staff.

Note: This work was performed prior to joining Stout.